The Intel-backed medical administration software provider has now raised almost $100m in financing in total and has just appointed a new chief executive.

Bright, the operator of health and wellness products site Healthkart, has spun out new business 1mg with money sourced from existing backers including Intel.

Pharmstandard was among the participants in the series B round, which lifted Jounce's overall funding above the $100m mark.

GlaxoSmithKine and Merck Serono, both existing investors of Auxogyn, have participated in a funding round for the newly merged company, dubbed Progyny.

A subsidiary of medical research firm DNAnexus provided the cash for the Google-backed genome data platform as part of a strategic agreement.

The Medical Mutual baked series B round will fund an increase in Contego's workforce and the development of new products based on its technology platform.

Taj Medical will use the money to advance clinical research for its neuromodulation device, intended to treat depression.

The Novartis and Johnson & Johnson-backed immuno-oncology company's shares opened at almost double their initial public offering value last week.

Siemens-backed ViewRay has postponed a $64m initial public offering that would have been used to help commercialise its radiation therapy system.